Antimicrobial agent-29, identified by its CAS number 731793-27-4, is a synthetic compound designed to exhibit antimicrobial properties. While specific characteristics may vary, compounds in this category typically demonstrate efficacy against a broad spectrum of microorganisms, including bacteria, fungi, and viruses. The mechanism of action often involves disrupting cellular processes or structures, such as inhibiting cell wall synthesis or interfering with nucleic acid function. Antimicrobial agent-29 may possess favorable pharmacokinetic properties, including good solubility and stability, which enhance its bioavailability. Additionally, it may be evaluated for its safety profile, including potential toxicity and side effects, to ensure it can be used effectively in clinical or agricultural applications. Research into such agents often focuses on their ability to combat resistant strains of pathogens, making them valuable in the ongoing fight against antimicrobial resistance. Further studies would typically explore its efficacy in various formulations and delivery methods, as well as its potential interactions with other therapeutic agents.

Antimicrobial agent-29

731793-27-4: Antimicrobial agent-29, identified by its CAS number 731793-27-4, is a synthetic compound designed to exhibit antimicrobial properties. While specific characteristics may vary, compounds in this category typically demonstrate efficacy against a broad spectrum of microorganisms, including bacteria, fungi, and viruses. The mechanism of action often involves disrupting cellular processes or structures, such as inhibiting cell wall synthesis or interfering with nucleic acid function. Antimicrobial agent-29 may possess favorable pharmacokinetic properties, including good solubility and stability, which enhance its bioavailability. Additionally, it may be evaluated for its safety profile, including potential toxicity and side effects, to ensure it can be used effectively in clinical or agricultural applications. Research into such agents often focuses on their ability to combat resistant strains of pathogens, making them valuable in the ongoing fight against antimicrobial resistance. Further studies would typically explore its efficacy in various formulations and delivery methods, as well as its potential interactions with other therapeutic agents.

<p>Antimicrobial Agent-29 (Compound C35) influences the interaction between human hemoglobin and the Staphylococcus aureus IsdB hemophore. This compound facilitates the identification of IsdB:Hb PPI inhibitors [1].</p>

CAS 731793-27-4

Antimicrobial agent-29

Antimicrobial agent-29

Ref: TM-T85694